NovoCure (NASDAQ: NVCR)
NovoCure Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
NovoCure Company Info
Novocure's tumor-treating field devices use electric fields to disrupt the replication of cancer cells.
News & Analysis
Why NovoCure Stock Was Winning Big This Week
Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?
NovoCure Beats Q3 Revenue, EPS Estimates
The cancer-treatment specialist demonstrated strong revenue growth, but on the bottom line, it's still losing money.
Why NovoCure Stock Dived by 13% This Week
Investors found the announced changes to the company's C-suite unsettling.
NovoCure's Q2 Revenue Soars by 10.7%
The oncology treatment pioneer delivered a robust report showcasing significant revenue growth and a clinical trial success.
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
Why NovoCure Stock Soared 18.3% This Week
Novocure announced encouraging results in a phase 3 trial for its TTFields therapy.
Why Novocure Stock Is Jumping Today
Novocure had good news mixed with some not-so-good news.
Valuation
Podcast Episodes
Why NovoCure's Regulatory News Is a Huge Win for Investors
The cancer-focused medical-device maker received the go-ahead to enter a brand-new market. Here's why the news should make investors giddy.
2 Winners and 2 Losers in the Med Tech Market This Quarter
Medical devices can be ultra reliable, lucrative business, but there are plenty of ways for companies to blow it, too.
3 Medical Device Companies for Your Watchlist
Recurring revenue, monopolistic market positions, and returns that tend to beat even the risky biotechs tie these three together.
Earnings Transcripts
NovoCure (NVCR) Q3 2024 Earnings Call Transcript
NVCR earnings call for the period ending September 30, 2024.
NovoCure (NVCR) Q2 2024 Earnings Call Transcript
NVCR earnings call for the period ending June 30, 2024.
NovoCure (NVCR) Q1 2024 Earnings Call Transcript
NVCR earnings call for the period ending March 31, 2024.
NovoCure (NVCR) Q4 2023 Earnings Call Transcript
NVCR earnings call for the period ending December 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.